BioKDE

Clinical Trial
Meta-Analysis
Randomized Controlled Trial
Review
Systematic Review

1 year

5 year

10 year

Start Date:

End Date:

2,314,780 results (0.514 seconds)

Antitumour actions of interferons: implications for cancer therapy.
Belinda S Parker, Jai Rautela, Paul J Hertzog.
Nat Rev Cancer. 2016 Feb 26; 16(3):131-44. PMID: 26911188
Highly Cited. Review.

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff.
Nature. 2018 Jan 25; 553(7689):446-454. PMID: 29364287
Highly Cited. Review.

New perspectives for targeting RAF kinase in human cancer.
Zoi Karoulia, Evripidis Gavathiotis, Poulikos I Poulikakos.
Nat Rev Cancer. 2017 Oct 06; 17(11):676-691. PMID: 28984291 Free PMC article
Highly Cited. Review.

Determinants and clinical implications of chromosomal instability in cancer.
Laurent Sansregret, Bart Vanhaesebroeck, Charles Swanton.
Nat Rev Clin Oncol. 2018 Jan 03; 15(3):139-150. PMID: 29297505
Highly Cited. Review.

Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.
Martin Reck, Klaus F Rabe.
N Engl J Med. 2017 Aug 31; 377(9):849-861. PMID: 28854088
Highly Cited. Review.

mTOR signalling and cellular metabolism are mutual determinants in cancer.
Dirk Mossmann, Sujin Park, Michael N Hall.
Nat Rev Cancer. 2018 Nov 15; 18(12):744-757. PMID: 30425336
Highly Cited. Review.

State-of-the-art strategies for targeting the DNA damage response in cancer.
Patrick G Pilié, Chad Tang, Gordon B Mills, Timothy A Yap.
Nat Rev Clin Oncol. 2018 Oct 26; 16(2):81-104. PMID: 30356138 Free PMC article
Highly Cited. Review.

A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization.
Miguel F Sanmamed, Lieping Chen.
Cell. 2018 Oct 06; 175(2):313-326. PMID: 30290139 Free PMC article
Highly Cited. Review.

Natural killer cells and other innate lymphoid cells in cancer.
Laura Chiossone, Pierre-Yves Dumas, Margaux Vienne, Eric Vivier.
Nat Rev Immunol. 2018 Sep 14; 18(11):671-688. PMID: 30209347
Highly Cited. Review.

Stem cell fate in cancer growth, progression and therapy resistance.
Nikki K Lytle, Alison G Barber, Tannishtha Reya.
Nat Rev Cancer. 2018 Sep 20; 18(11):669-680. PMID: 30228301 Free PMC article
Highly Cited. Review.

Advances and challenges in targeting FGFR signalling in cancer.
Irina S Babina, Nicholas C Turner.
Nat Rev Cancer. 2017 Mar 17; 17(5):318-332. PMID: 28303906
Highly Cited. Review.

Charged-particle therapy in cancer: clinical uses and future perspectives.
Marco Durante, Roberto Orecchia, Jay S Loeffler.
Nat Rev Clin Oncol. 2017 Mar 14; 14(8):483-495. PMID: 28290489
Highly Cited. Review.

The Principles of Engineering Immune Cells to Treat Cancer.
Wendell A Lim, Carl H June.
Cell. 2017 Feb 12; 168(4):724-740. PMID: 28187291 Free PMC article
Highly Cited. Review.

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.
Yijing Liu, Pravin Bhattarai, Zhifei Dai, Xiaoyuan Chen.
Chem Soc Rev. 2018 Sep 28; 48(7):2053-2108. PMID: 30259015 Free PMC article
Highly Cited. Review.

Advances in the treatment of advanced oestrogen-receptor-positive breast cancer.
Nicholas C Turner, Patrick Neven, Sibylle Loibl, Fabrice Andre.
Lancet. 2016 Dec 07; 389(10087):2403-2414. PMID: 27939057
Highly Cited. Review.

Contextual determinants of TGFβ action in development, immunity and cancer.
Charles J David, Joan Massagué.
Nat Rev Mol Cell Biol. 2018 Apr 13; 19(7):419-435. PMID: 29643418 Free PMC article
Highly Cited. Review.

γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.
Bruno Silva-Santos, Sofia Mensurado, Seth B Coffelt.
Nat Rev Cancer. 2019 Jun 19; 19(7):392-404. PMID: 31209264 Free PMC article
Highly Cited. Review.

Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion.
José Pedro Friedmann Angeli, Dmitri V Krysko, Marcus Conrad.
Nat Rev Cancer. 2019 May 19; 19(7):405-414. PMID: 31101865
Highly Cited. Review.

The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies.
Laurence Zitvogel, Yuting Ma, +2 authors, Thomas F Gajewski.
Science. 2018 Mar 24; 359(6382):1366-1370. PMID: 29567708
Highly Cited. Review.

Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku, Timothy A Yap, Funda Meric-Bernstam.
Nat Rev Clin Oncol. 2018 Mar 06; 15(5):273-291. PMID: 29508857
Highly Cited. Review.

Previous

Next